Additionally, Dobrzycka et al. evaluated the significance of KRAS gene mutations, blood plasma p53 antibodies (p53-Ab), and circulating free DNA (CFDNA) in the prognosis of 126 patients with epithelial ovarian cancer. Here, TP53 is linked to ovarian carcinoma.